EUVIMEDEUVIMED entdecken
Crossref

Targeting activated kidney fibroblasts via ferroptosis: a potential antifibrotic strategy

Inga Sörensen-Zender iD, Rong Song, Julius Sinning, Tamar Kapanadze, Kai M Schmidt-Ott iD, Anette Melk iD, Roland Schmitt iD

American Journal of Physiology-Cell Physiology · 2026

DOI: 10.1152/ajpcell.00660.2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2026. Verfasst von Inga Sörensen-Zender und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, Hannover Medical School, Germany. Hauptthemen laut MEDLINE: Ferroptosis, Kidney, Fibroblasts, Myofibroblasts. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft (DFG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study reveals ferroptosis, a pharmacologically inducible form of cell death, as a novel mechanism to eliminate activated fibroblasts, the main drivers of kidney fibrosis. Due to their high ferroptosis sensitivity, these cells are selectively depleted by RSL3 in vitro, in kidney tissue slice cultures, and in fibrotic kidneys in vivo. These findings highlight ferroptosis induction as a promising antifibrotic strategy in kidney disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisKidneyFibroblastsMyofibroblastsCarbolinesAntifibrotic AgentsKidney DiseasesAnimalsFibrosisMiceMice, Inbred C57BLMaleTransforming Growth Factor beta

Stichwörter der Autor:innen

TGF-βferroptosisfibroblastsfibrosiskidney

Substanzen

CarbolinesRSL3 compoundTransforming Growth Factor betaAntifibrotic Agents

Autor:innen und Institutionen

  • Department of Nephrology and Hypertension, Hannover Medical School, Germany.
  • Vascular Medicine Research, Hannover Medical School, Hannover, Germany.
  • Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany.
  • Department of Nephrology and Hypertension, University Hospital Schleswig-Holstein, Kiel, Germany.

ORCID-Profile: Inga Sörensen-Zender, Kai M Schmidt-Ott, Anette Melk, Roland Schmitt

Förderung

  • Deutsche Forschungsgemeinschaft (DFG)

Zitieren

APA

Sörensen-Zender, I., Song, R., Sinning, J., Kapanadze, T., Schmidt-Ott, K. M., Melk, A., & Schmitt, R. (2026). Targeting activated kidney fibroblasts via ferroptosis: a potential antifibrotic strategy. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00660.2025

Vancouver

Sörensen-Zender I, Song R, Sinning J, Kapanadze T, Schmidt-Ott KM, Melk A, et al. Targeting activated kidney fibroblasts via ferroptosis: a potential antifibrotic strategy. American Journal of Physiology-Cell Physiology. 2026. doi:10.1152/ajpcell.00660.2025

BibTeX
@article{SrensenZender2026,
  author = {Sörensen-Zender, Inga and Song, Rong and Sinning, Julius and Kapanadze, Tamar and Schmidt-Ott, Kai M and Melk, Anette and Schmitt, Roland},
  title = {Targeting activated kidney fibroblasts via ferroptosis: a potential antifibrotic strategy},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2026},
  doi = {10.1152/ajpcell.00660.2025}
}
Kostenlos starten →